Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDTherapeuticsMD Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | -$6.13 | -$6.13 | -$6.13 |
| Q2 2026 | 1 | -$5.50 | -$5.50 | -$5.50 |
| Q3 2026 | 1 | -$5.00 | -$5.00 | -$5.00 |
| Q4 2026 | 1 | -$3.83 | -$3.83 | -$3.83 |
| Q1 2027 | 1 | -$4.00 | -$4.00 | -$4.00 |
| Q2 2027 | 1 | -$3.04 | -$3.04 | -$3.04 |
| Q3 2027 | 1 | -$0.57 | -$0.57 | -$0.57 |
| Q4 2027 | 1 | $0.06 | $0.06 | $0.06 |
| Q1 2028 | 1 | -$0.07 | -$0.07 | -$0.07 |
| Q2 2028 | 1 | -$0.15 | -$0.15 | -$0.15 |
| Q3 2028 | 1 | -$0.13 | -$0.13 | -$0.13 |
| Q4 2028 | 1 | $0.03 | $0.03 | $0.03 |
| Q1 2029 | 1 | $0.03 | $0.03 | $0.03 |
| Q2 2029 | 1 | $0.04 | $0.04 | $0.04 |
| Q3 2029 | 1 | $0.04 | $0.04 | $0.04 |
TherapeuticsMD Inc Earnings Date And Information
TherapeuticsMD Inc last posted its earnings results on Monday, March 30th, 2026. The company reported $-0.0542 earnings per share for the quarter, topping analysts' consensus estimates of $-6.125 by $6.0708. The company had revenue of 893.00 K for the quarter and had revenue of 3.02 M for the year. TherapeuticsMD Inc has generated $0 earnings per share over the last year ($-0.0492 diluted earnings per share) and currently has a price-to-earnings ratio of -42.29. TherapeuticsMD Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
TherapeuticsMD Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/30/2026 | Q4 2025 | -$6.13 | -$0.05 | 6.07 | $19.77 M | $893.00 K |
| 11/12/2025 | Q3 2025 | N/A | $0.01 | N/A | N/A | $784.00 K |
| 08/12/2025 | Q2 2025 | N/A | $0.05 | N/A | N/A | $952.00 K |
| 05/13/2025 | Q1 2025 | N/A | -$0.06 | N/A | $2.30 M | $393.00 K |
| 04/30/2025 | Q4 2024 | N/A | $0.02 | N/A | $2.30 M | $667.00 K |
| 11/12/2024 | Q3 2024 | $0.04 | -$0.05 | -0.09 | $2.20 M | $547.00 K |
| 08/12/2024 | Q2 2024 | $0.03 | -$0.09 | -0.12 | $2.20 M | $234.00 K |
| 05/10/2024 | Q1 2024 | $0.03 | -$0.06 | -0.09 | N/A | $313.00 K |
| 04/29/2024 | Q4 2023 | N/A | -$0.08 | N/A | N/A | $502.00 K |
| 09/29/2023 | Q3 2023 | N/A | -$0.32 | N/A | N/A | $-53,000 |
| 08/14/2023 | Q2 2023 | -$0.07 | -$0.24 | -0.17 | N/A | $437.00 K |
| 05/15/2023 | Q1 2023 | $0.06 | -$0.37 | -0.43 | N/A | $416.00 K |
| 04/07/2023 | Q4 2022 | N/A | -$3.55 | N/A | N/A | $1.15 M |
| 11/14/2022 | Q3 2022 | -$2.04 | -$3.13 | -1.09 | N/A | $20.92 M |
| 08/15/2022 | Q2 2022 | -$3.04 | $12.83 | 15.87 | N/A | $28.56 M |
| 05/16/2022 | Q1 2022 | -$3.50 | -$8.36 | -4.86 | N/A | $19.33 M |
| 03/23/2022 | Q4 2021 | N/A | -$5.03 | N/A | N/A | $18.68 M |
| 11/12/2021 | Q3 2021 | N/A | -$5.62 | N/A | N/A | $25.41 M |
| 08/04/2021 | Q2 2021 | -$5.50 | -$5.41 | 0.09 | N/A | $23.00 M |
| 05/06/2021 | Q1 2021 | -$5.00 | -$5.67 | -0.67 | N/A | $19.87 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
TherapeuticsMD Inc Earnings: FAQ's
In the previous quarter, TherapeuticsMD Inc (:TXMD) reported $-0.0542 earnings per share (EPS) to beat the analysts' consensus estimate of $-6.125 by $6.0708.
The conference call for TherapeuticsMD Inc's latest earnings report can be listened to online.
The conference call transcript for TherapeuticsMD Inc's latest earnings report can be read online.
TherapeuticsMD Inc (:TXMD) has a recorded annual revenue of $3.02 M.
TherapeuticsMD Inc (:TXMD) has a recorded net income of $-569,000.TherapeuticsMD Inc has generated $-0.0492 earnings per share over the last four quarters.
TherapeuticsMD Inc (:TXMD) has a price-to-earnings ratio of -42.29 and price/earnings-to-growth ratio is 0.04.